Kazia Therapeutics Limited (KZIA) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$11.98
+0.21%
Mkt Cap $13.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | — | $253.00K | — | -$0.01 | -$0.41 | -5760.55% | — | — |
| Q2 2025 Jun 30, 2025 | $10.45K | $12.87K | +23.17% | -$0.01 | -$4.18 | -63968.61% | — | — |
| Q2 2025 May 28, 2025 | — | $13.80K | — | -$10.76 | -$7.61 | +29.29% | — | — |
| Q4 2024 Nov 19, 2024 | $100.00K | $1.65M | +1554.23% | -$15.00 | -$20.81 | -38.75% | — | — |
| Q1 2024 Mar 27, 2024 | — | $3 | — | — | -$12.53 | — | — | — |
| Q4 2023 Nov 27, 2023 | — | $664 | — | -$1.66 | -$10.02 | -504.79% | — | — |
| Q1 2023 Mar 9, 2023 | $7.75K | — | — | -$24.65 | -$31.86 | -29.27% | — | — |
| Q4 2022 Oct 6, 2022 | — | — | — | — | -$30.53 | — | — | — |
| Q1 2022 Jan 6, 2022 | — | $7.25K | — | — | -$36.25 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $11.40M | — | — | -$5.85 | — | — | — |
| Q4 2020 Dec 31, 2020 | $456.57K | $897 | -99.80% | -$2.30 | -$22.72 | -885.78% | — | — |
| Q2 2020 Jun 30, 2020 | $2.37M | $251.13K | -89.39% | — | -$26.84 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | $440.05K | — | — | -$30.27 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | $469.59K | — | — | -$22.86 | — | — | — |
| Q4 2018 Dec 31, 2018 | — | $594.07K | — | — | -$42.21 | — | — | — |
| Q2 2018 Jun 30, 2018 | — | $1.14M | — | — | -$47.10 | — | — | — |
| Q4 2017 Dec 31, 2017 | — | $1.12M | — | — | $3.24 | — | — | — |
| Q3 2017 Aug 30, 2017 | — | $3.22M | — | — | -$49.24 | — | — | — |
| Q1 2017 Feb 22, 2017 | — | $3.30M | — | — | -$31.88 | — | — | — |
| Q3 2016 Aug 30, 2016 | — | $176.14K | — | — | -$68.46 | — | — | — |
| Q1 2016 Feb 22, 2016 | — | $2.21M | — | — | -$32.85 | — | — | — |
| Q3 2015 Aug 31, 2015 | — | $98.21K | — | — | -$61.89 | — | — | — |
| Q1 2015 Feb 28, 2015 | — | $1.37M | — | — | -$54.79 | — | — | — |
| Q4 2014 Oct 3, 2014 | — | $375.29K | — | — | -$123.00 | — | — | — |
| Q1 2014 Feb 28, 2014 | — | $29.30K | — | — | -$105.75 | — | — | — |
| Q2 2013 Jun 30, 2013 | — | $468.99K | — | — | -$57.10 | — | — | — |
| Q4 2012 Dec 31, 2012 | — | $629.04K | — | — | -$11.46 | — | — | — |
| Q2 2012 Jun 30, 2012 | — | $1.24M | — | — | $32.32 | — | — | — |
| Q4 2011 Dec 31, 2011 | — | $1.24M | — | — | $32.42 | — | — | — |
| Q2 2011 Jun 30, 2011 | — | $1.08M | — | — | -$170.13 | — | — | — |
| Q4 2010 Dec 31, 2010 | — | $1.03M | — | — | -$161.75 | — | — | — |
| Q2 2010 Jun 30, 2010 | — | $4.18M | — | — | -$254.69 | — | — | — |
| Q4 2009 Dec 31, 2009 | — | $4.44M | — | — | -$270.85 | — | — | — |
| Q2 2009 Jun 30, 2009 | — | $4.46M | — | — | -$371.82 | — | — | — |
| Q4 2008 Dec 31, 2008 | — | $4.52M | — | — | -$377.07 | — | — | — |
| Q2 2008 Jun 30, 2008 | — | $6.37M | — | — | -$498.06 | — | — | — |
| Q4 2007 Dec 31, 2007 | — | $5.30M | — | — | -$415.19 | — | — | — |
| Q2 2007 Jun 30, 2007 | — | $7.34M | — | — | -$395.08 | — | — | — |
| Q4 2006 Dec 31, 2006 | — | $6.82M | — | — | -$404.66 | — | — | — |
| Q2 2006 Jun 30, 2006 | — | $4.98M | — | — | -$308.26 | — | — | — |
| Q4 2005 Dec 31, 2005 | — | $4.92M | — | — | -$304.86 | — | — | — |
| Q2 2005 Jun 30, 2005 | — | $6.67M | — | — | -$308.44 | — | — | — |
| Q4 2004 Dec 31, 2004 | — | $6.85M | — | — | -$243.45 | — | — | — |
| Q2 2004 Jun 30, 2004 | — | $5.72M | — | — | -$216.08 | — | — | — |
| Q4 2003 Dec 31, 2003 | — | $5.27M | — | — | -$182.82 | — | — | — |
| Q2 2003 Jun 30, 2003 | — | $11.18M | — | — | -$181.22 | — | — | — |
| Q1 2003 Mar 3, 2003 | — | $8.65M | — | — | -$143.26 | — | — | — |
| Q2 2002 Jun 30, 2002 | — | $5.51M | — | — | -$213.91 | — | — | — |
| Q4 2001 Dec 31, 2001 | — | $5.53M | — | — | -$217.53 | — | — | — |
| Q2 2001 Jun 30, 2001 | — | $15.14M | — | — | -$639.95 | — | — | — |
| Q4 2000 Dec 31, 2000 | — | $16.93M | — | — | -$722.11 | — | — | — |
| Q2 2000 Jun 30, 2000 | — | -$1.28M | — | — | $1590.38 | — | — | — |
| Q4 1999 Dec 31, 1999 | — | $11.66M | — | — | -$1395.52 | — | — | — |
| Q2 1999 Jun 30, 1999 | — | $6.43M | — | — | -$498.08 | — | — | — |
| Q4 1998 Dec 30, 1998 | — | $5.91M | — | — | -$458.47 | — | — | — |